Loading
 จารุพงษ์  แสงบุญมี

จารุพงษ์ แสงบุญมี

ภาควิชาชีวเคมี,
คณะแพทยศาสตร์,
มหาวิทยาลัยขอนแก่น
56598021900: H-INDEX 5

บทความ

TCI อ้างอิงจาก http://www.tci-thaijo.org/

0

SCOPUS

0

PUBMED

0

ISI

0

TCI

Title Author Year SCOPUS PUBMED ISI TCI
1. Diabetes mellitus: Possible risk and promoting factors of cholangiocarcinoma. Association of diabetes mellitus and cholangiocarcinoma Saengboonmee, C.
Seubwai, W.
Wongkham, C.
Wongkham, S.
2015
2. High glucose enhances progression of cholangiocarcinoma cells via STAT3 activation Saengboonmee, C.
Seubwai, W.
Pairojkul, C.
Wongkham, S.
2016
3. High glucose levels boost the aggressiveness of highly metastatic cholangiocarcinoma cells via O-GlcNAcylation Phoomak, C.
Vaeteewoottacharn, K.
Silsirivanit, A.
Saengboonmee, C.
Seubwai, W.
Sawanyawisuth, K.
Wongkham, C.
2017
4. Metformin exerts antiproliferative and anti-metastatic effects against cholangiocarcinoma cells by targeting STAT3 and NF-κB Saengboonmee, C.
Seubwai, W.
Cha'on, U.
Sawanyawisuth, K.
Wongkham, C.
2017
5. Prognostic biomarkers for cholangiocarcinoma and their clinical implications Saengboonmee, C.
Sawanyawisuth, K.
Chamgramol, Y.
Wongkham, S.
2018
6. Overexpression of HexCer and LacCer containing 2-hydroxylated fatty acids in cholangiocarcinoma and the association of the increase of LacCer (d18:1-h23:0) with shorter survival of the patients Silsirivanit, A.
Phoomak, C.
Seubwai, W.
Saengboonmee, C.
Wongkham, S.
2019
Count 6 0 0 0

Title Authors Year Publication name Cited count
< 2015 2016 2017 2018 2019 2020 รวม
1. Diabetes mellitus: Possible risk and promoting factors of cholangiocarcinoma. Association of diabetes mellitus and cholangiocarcinoma Saengboonmee, C.
Seubwai, W.
Wongkham, C.
Wongkham, S.
2015 Cancer Epidemiology
3 (39), pp. 274-278
2. High glucose enhances progression of cholangiocarcinoma cells via STAT3 activation Saengboonmee, C.
Seubwai, W.
Pairojkul, C.
Wongkham, S.
2016 Scientific Reports
(6), pp.
3. High glucose levels boost the aggressiveness of highly metastatic cholangiocarcinoma cells via O-GlcNAcylation Phoomak, C.
Vaeteewoottacharn, K.
Silsirivanit, A.
Saengboonmee, C.
Seubwai, W.
Sawanyawisuth, K.
Wongkham, C.
2017 Scientific Reports
(7), pp.
4. Metformin exerts antiproliferative and anti-metastatic effects against cholangiocarcinoma cells by targeting STAT3 and NF-κB Saengboonmee, C.
Seubwai, W.
Cha'on, U.
Sawanyawisuth, K.
Wongkham, C.
2017 Anticancer Research
1 (37), pp. 115-123
5. Prognostic biomarkers for cholangiocarcinoma and their clinical implications Saengboonmee, C.
Sawanyawisuth, K.
Chamgramol, Y.
Wongkham, S.
2018 Expert Review of Anticancer Therapy
6 (18), pp. 579-592
6. Overexpression of HexCer and LacCer containing 2-hydroxylated fatty acids in cholangiocarcinoma and the association of the increase of LacCer (d18:1-h23:0) with shorter survival of the patients Silsirivanit, A.
Phoomak, C.
Seubwai, W.
Saengboonmee, C.
Wongkham, S.
2019 Glycoconjugate Journal
(), pp.

Title Authors Year Journal title

Title Authors Year Journal title Cited count
< 2015 2016 2017 2018 2019 2020 รวม

Title Authors Year Journal title

ชื่อโครงการ Authors ประเภทโครงการ ปีงบประมาณ ทุนวิจับ

0.046366214752197266